pharmacycanada-rxedtop

A dangerous mix: Rural living, chronic illness make COVID-19 particularly dangerous for Prairie native | News

Editor’s Note: The Human Impact is an ongoing series about the disproportionate impact of COVID-19 on…

Coronavirus live news: restrictions tighten in Europe; antibody treatment trial paused | World news

The international community’s response to global food insecurity is “dangerously inadequate”, the NGO Oxfam said in…

Amid COVID-19, Pro-Lifers Push to Avoid Abortive Fetal Cel…… | News & Reporting

Carolyn Nelson Kathryn McQuaid David Constance Willie Lewis Miel Horrilleno Nathan Chan Thian Hup Tan Julia…

Health Coverage Takes Big Hit With Pandemic-Related Job Cuts | Health News

By Robert Preidt, HealthDay Reporter (HealthDay) TUESDAY, Oct. 13, 2020 (HealthDay News) — Up to 7.7…

Ionis’ inhaled antisense medicine demonstrates potential as a novel treatment for cystic fibrosis | News

CARLSBAD, Calif., Oct. 13, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics,…

No shelter in place: Concord-Carlisle food pantry program seeks indoor location – News – Wicked Local

Editor’s note: Vital coronavirus stories are being provided for free as a public service to our…

How Long Can I Expect a COVID-19 Illness to Last? | Health News

How long can I expect a COVID-19 illness to last? It depends. Most coronavirus patients have…

Local News: Community Clinic partners with Meharry Dentistry (10/13/20)

Meharry Medical College School of Dentistry has partnered with the free Community Clinic on Dover Street…

Takeda Group Begins Manufacturing COVID-19 Plasma Treatment Ahead of Approval | Top News

NEW YORK (Reuters) – The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment…

MYXfitness Is The First At-Home Fitness Brand to Integrate National News, Plus a Full Suite of Revolutionary Content On Its Platform

MYXfitness, the smarter, simpler home-fitness solution, announces MYX Media, a new hub for original content. Tweet…